These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3309820)

  • 1. [Cytomorphological study of the action of ornidazole against Bacteroides fragilis].
    Attisso MA; Dusart G; Simeon De Buochberg M; Zuccarelli M
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):813-8. PubMed ID: 3309820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro.
    Jokipii L; Jokipii AM
    J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119
    [No Abstract]   [Full Text] [Related]  

  • 3. Scanning electron microscopic examination of Bacteroides fragilis and Gardnerella vaginalis after exposure to concentration gradients of metronidazole and tinidazole.
    Skarin A; Mårdh PA
    Scand J Infect Dis Suppl; 1981; 26():54-9. PubMed ID: 6972572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of ornidazole against anaerobic organisms. Differences seen in certain strains in relation to the partial pressure of oxygen. (author's transl)].
    Peloux Y; Giacchero E
    Nouv Presse Med; 1978 May; 7(18):1562. PubMed ID: 209402
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning of a Bacteroides fragilis chromosomal determinant coding for 5-nitroimidazole resistance.
    Haggoud A; Reysset G; Sebald M
    FEMS Microbiol Lett; 1992 Aug; 74(1):1-5. PubMed ID: 1516803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.
    Jokipii L; Jokipii AM
    Antimicrob Agents Chemother; 1985 Oct; 28(4):561-4. PubMed ID: 4073879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metronidazole on surface properties of Bacteroides fragilis.
    Cavalcanti SM; Domingues RM; Ferreira MC; Costa e Silva Filho F
    J Antimicrob Chemother; 1991 Dec; 28(6):819-26. PubMed ID: 1816180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of meningitis caused by Bacteroides fragilis with injections of ornidazole].
    Cadoz M; Deborne B; Lafaix C; Langlois-Zantain O; Dublanchet A
    Nouv Presse Med; 1977 Jul 2-9; 6(27):2438-9. PubMed ID: 896422
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
    Goldstein EJ; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1978 Oct; 14(4):609-13. PubMed ID: 718156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis.
    Pumbwe L; Skilbeck CA; Nakano V; Avila-Campos MJ; Piazza RM; Wexler HM
    Microb Pathog; 2007; 43(2-3):78-87. PubMed ID: 17524609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of anaerobic bacteria to nitroimidazoles.
    Olsson-Liljequist B; Nord CE
    Scand J Infect Dis Suppl; 1981; 26():42-5. PubMed ID: 6941455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteroides fragilis and nitroimidazoles.
    Ferguson IR; Smith LL
    J Antimicrob Chemother; 1976 Jun; 2(2):220-1. PubMed ID: 956086
    [No Abstract]   [Full Text] [Related]  

  • 16. Ornidazole and anaerobic bacteria: in vitro sensitivity and effects on wound infections after appendectomy.
    Palmu A; Renkonen OV; Aromaa U
    J Infect Dis; 1979 May; 139(5):586-9. PubMed ID: 220342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study, using 3 methods, of the sensitivity to metronidazole and ornidazole of anaerobic or related bacteria].
    Gallusser A
    Ann Microbiol (Paris); 1983; 134B(2):307-21. PubMed ID: 6651124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
    Menozzi M; Avanzini P; Lecchini R; Bigi M; Chezzi C
    Chemioterapia; 1987 Jun; 6(2 Suppl):88-91. PubMed ID: 3509541
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro anti-fungal activity of the econazole-ornidazole combination (1:10 ratio)].
    Piccolomini R; Arpini A; Cellini L; Pagano M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):257-61. PubMed ID: 6639779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.